News › Industry News, News

Law Firm Announces It Is Investigating Evolus on Behalf of Evolus Stockholders

September 9, 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Evolus, Inc. on behalf of Evolus stockholders. Its investigation concerns whether Evolus has violated the federal securities laws and/or engaged in other unlawful business practices.
Evolus is a California-based medical aesthetics company. The company and its South Korean partner, Daewoong Pharmaceutical Co., developed Jeuveau, a competitor to Allergan’s Botox. Jeuveau has recently become a strong, more affordable competitor of Botox.
Read more at GlobeNewswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
    • Allergan Aesthetics Debuts AA Signature in the United States with SKIN360
    • Candela Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Approves Additional Warning for Kybella Labeling
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
Advertisement